R. Russell‐Jones

Response to Imatinib Mesylate in Patients with Chronic Myeloproliferative Diseases with Rearrangements of the Platelet-Derived Growth Factor Receptor Beta

Jane F. Apperley, Martine Gardembas, Junia V. Melo et al. · New England Journal of Medicine · 2002 · 631 citations · Full text

Medicine, Hematology, Molecular Genetics +16

Cytotoxic/natural killer cell cutaneous lymphomas

Marco Santucci, Nicola Pimpinelli, Daniela Massi et al. · Cancer · 2003 · 273 citations · Full text

Medicine, Oncology, Pathology +17

Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas

Xin Mao, Guy Orchard, Debra M. Lillington et al. · Blood · 2003 · 194 citations · Full text

Medicine, Oncology, Pathology +12

Durable responses to imatinib in patients with PDGFRB fusion gene–positive and BCR-ABL–negative chronic myeloproliferative disorders

Marianna Dávid, Nicholas C.P. Cross, Sonja Burgstaller et al. · Blood · 2006 · 173 citations · Full text

Medicine, Clinical Sciences, Hematology +5

Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD)

FJ Child, R. Ratnavel, P Watkins et al. · Bone Marrow Transplantation · 1999 · 170 citations

Medicine, Immunology, Hemodialysis +11